Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. (Q35680962)
Jump to navigation
Jump to search
scientific article published on 11 August 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain. |
scientific article published on 11 August 2011 |
Statements
Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain (English)
Katherine J Motyl
Ingrid Dick-de-Paula
Ann E Maloney
Sutada Lotinun
Sheila Bornstein
Roland Baron
Karen L Houseknecht
Clifford J Rosen
11 August 2011
1 reference
1 reference